SIRT3 overexpression in colorectal cancer cells also decreased FoxO3a acetylation and increased FoxO3a binding to the SOD2 promoter, whereas expression of a SIRT3 catalytic mutant did not affect the DNA binding ability of FoxO3a [121]. This evidence concerns the gene SOD2 and colorectal cancer.